Results for "Understanding Pharmaceutical Distribution"
HDA’s Chip Davis Discusses How to Build a More Resilient Global Supply Chain
HDA President and CEO Chip Davis participated in the Aspen Institute’s 2021 Aspen Security Forum as part of a panel discussion entitled, "Building a More Resilient Global Supply Chain."
HDA Recommends a Phased Approach to Implementing the Final Requirements of the DSCSA
The Healthcare Distribution Alliance (HDA) is recommending to the Food and Drug Administration (FDA) a phased approach to final implementation of the Drug Supply Chain Security Act (DSCSA) to minimize the potential for supply disruptions and interruptions to patient care. The proposal was communicated through a recent letter to FDA.
Distributors Rising to the Challenge During the Coronavirus Pandemic
As the impact of COVID-19 “coronavirus” pandemic continues to unfold, we are all deeply concerned about our personal health and well-being — and that of our loved ones. As Americans worry about when their workplaces or schools will reopen, or if they have an adequate supply of necessary household staples, many also have heightened concerns about whether they will be able to access the vital medications and healthcare products they rely on each day.
Health Delivered: Reaffirming Distributors' Fundamental Value to U.S. Healthcare
For the past year, I have watched the men and women of the healthcare distribution industry go above and beyond on a daily basis to make sure medicines, vaccines, PPE and other medical supplies reached patients and providers across the country. Their energy, determination and commitment have ensured a resilient supply chain during the most challenging days of the COVID-19 pandemic and a distribution network that has continued to deliver value each and every day.